Screening mammography in SUS before and during the Covid-19 Pandemic: a comparison between biennia

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.32738

Keywords:

Breast Cancer; Mammography; Covid-19; SUS.

Abstract

Breast cancer is the most common among women. Screening actions aim to reduce morbidity and mortality from this neoplasm, identifying tumors in early stages to improve the chances of rehabilitation and cure. Objective: to analyze whether there was a reduction or increase in mammography rates in the 2020-2021 biennium compared to the 2018-2019 biennium in Brazil, its Regions, and Federation Units. Method: through DATASUS population projection data and SUS-approved mammograms in women aged 50 to 69 years, in the years 2018 to 2021, the coverage rates of examinations by women achieved and the reduction or increase of these rates were calculated. between biennia. Results: in general, Brazil showed a reduction of about 30% of exams in 2020/2021 compared to 2018/2019. In the South Region, the greatest reduction was observed: 33% fewer mammograms, while the North Region presented the smallest: approximately 11% reduction. Among the Federation Units, there was an increase in mammograms performed during the pandemic in the Federal District (25%), Roraima (15%), Pará (5%) and Amapá, which reached 3,228%, in contrast to the others. States, which showed a reduction in the same period. Conclusion: there was a national reduction of about 30% in the number of mammograms approved by the SUS in the 2020-2021 biennium compared to 2018-2019. Despite this, the Federal District, Roraima, Pará and Amapá showed positive rates, which may indicate good public health actions aimed at screening, which could be replicated in future policies by the other states.

References

ABRAMED. (2021). Mamografia – Número de exames cai pela metade na pandemia. https://abramed.org.br/2217/mamografia-numero-de-exames-cai-pela-metade-na-pandemia/

Bernards, R., & Weinberg, R. A. (2002). Metastasis genes: A progression puzzle. Nature, 418(6900), 823–823. https://doi.org/10.1038/418823a

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

CONASS. (2020). GDF amplia a oferta e zera fila de exames de mamografia. https://www.conass.org.br/gdf-amplia-a-oferta-e-zera-fila-de-exames-de-mamografia/

Freitas-Junior, R., Cristina Netto Rodrigues, D., Silveira Corrêa, R., Fernando Pádua Oliveira, L., Soares Couto, L., Augusta Brolini Dellê Urban, L., & Macedo Sousa Rahal, R. (2020). Opportunistic mammography screening by the Brazilian Unified Health System in 2019. Mastology, 30, 20190030. https://doi.org/10.29289/25945394202020190030

Gebrim, L. H. (2016). A detecção precoce do câncer de mama no Brasil. Cadernos de Saúde Pública, 32(5), 516–523. https://doi.org/10.1590/0102-311XCO010516

Gomes, M. (2022). Agência Brasília. https://www.agenciabrasilia.df.gov.br/2022/02/05/mais-de-28-mil-exames-de-mama-por-mes-no-ano-passado/

IARC. (2017). Breast Cancer Screening (W. Press (ed.); 2a, Vol. 15). IARC Working Group on the Evaluation of Cancer-Preventive Strategies.

IARC. (2020). World cancer report 2020. In World Health Organization. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014

INCA. (2019). Confira as recomendações do Ministério da Saúde para o rastreamento do câncer de mama. https://www.inca.gov.br/noticias/confira-recomendacoes-do-ministerio-da-saude-para-o-rastreamento-do-cancer-de-mama

INCA. (2020a). Estimativa 2020. https://www.inca.gov.br/estimativa/introducao

INCA. (2020b). Nota técnica - DIDEPRE/CONPREV/INCA - Rastreamento do câncer durante a pandemia de COVID-19. https://www.inca.gov.br/publicacoes/notas-tecnicas/deteccao-precoce-de-cancer-durante-pandemia-de-covid-19

INCA. (2021a). PARÂMETROS TÉCNICOS PARA O RASTREAMENTO DO CÂNCER DE MAMA. http://controlecancer.bvs.br/

INCA. (2021b). Vacina contra Covid-19 pode gerar erros de interpretação em mamografias. https://www.inca.gov.br/noticias/vacina-contra-covid-19-pode-gerar-erros-de-interpretacao-em-mamografias

Instituto Nacional de Câncer José Alencar Gomes da Silva. (2019). Câncer no Brasil. 4, 488. http://www.inca.gov.br/cancernobrasil/2010/docs/registro de base populacional_completo.pdf

Migowski, A., Dias, M. B. K., Nadanovsky, P., Azevedo E Silva, G., Sant’Ana, D. R., & Stein, A. T. (2018). Guidelines for early detection of breast cancer in Brazil. III – Challenges for implementation. Cadernos de Saude Publica, 34(6). https://doi.org/10.1590/0102-311X00046317

Rodrigues, D. C. N., Freitas-Junior, R., Rahal, R. M. S., da Silveira Corrêa, R., Gouveia, P. A., Peixoto, J. E., Martins, E., & Soares, L. R. (2019). Temporal changes in breast cancer screening coverage provided under the Brazilian National Health Service between 2008 and 2017. BMC Public Health, 19(1), 959. https://doi.org/10.1186/s12889-019-7278-z

SBM. (2020). Rastreamento mamográfico despenca no Brasil - SBM. Sociedade Brasileira de Mastologia. https://www.sbmastologia.com.br/noticias/rastreamento-mamografico-despenca-no-brasil/

SBM. (2021). Nota técnica – Informações atualizadas sobre vacinação contra COVID-19 e Mamografia. SBM. https://sbmastologia.com.br/atencao-nota-tecnica-informacoes-atualizadas-sobre-vacinacao-contra-covid-19-e-mamografia/

Resolução no 012/21 - CIB/AP, de 28 de abril de 2021, (2021). https://editor.amapa.gov.br/arquivos_portais/publicacoes/SESA_ea4f700fb093ec6508da3d085b8073a4.pdf

SESAU. (2021). Secretaria de Estado da Saúde de Roraima - SESAU. https://www.saude.rr.gov.br/index.php/component/content/article/20-noticias/805-mais-saude-para-as-mulheres-centro-de-referencia-passa-por-mudancas-para-reforcar-atendimento-na-unidade

SESPA. (2021). Poli Metropolitana oferta 300 mamografias e 300 consultas na mastologia em programação do Outubro Rosa – SESPA. http://www.saude.pa.gov.br/poli-metropolitana-oferta-300-mamografias-e-300-consultas-na-mastologia-em-programacao-do-outubro-rosa/?tribe-bar-date=2020-08-04&eventDisplay=past

SESPA. (2022). Mamografia ajuda o diagnóstico precoce do câncer de mama e aumenta chances de cura – SESPA. http://www.saude.pa.gov.br/mamografia-ajuda-o-diagnostico-precoce-do-cancer-de-mama-e-aumenta-chances-de-cura/

Silva, R. C. F., & Hortale, V. A. (2012). Rastreamento do Câncer de Mama no Brasil : Quem , Como e Por quê ? Breast cancer Screening in Brazil : Who , How and Why ? Revista Brasileira de Cancerologia, 58(1), 67–71. http://www.inca.gov.br/rbc/n_58/v01/pdf/10b_artigo_opiniao_rastreamento_cancer_mama_brasil_quem_como_por_que.pdf

WHO. (2007). WHO guide for effective programmes: Early detection. Cancer Control: Knowledge into Action, 3–39. https://www.ncbi.nlm.nih.gov/books/NBK195408/pdf/Bookshelf_NBK195408.pdf%0Ahttps://books.google.com.tr/books?hl=tr&lr=&id=3hVf8Ewh8xUC&oi=fnd&pg=PA2&dq=WHO+breast+cancer+target+group+%2570+who&ots=a7ByYtb_Yi&sig=c6RXwPitlX_bEyj4hmRyazNpP78&redir_esc=y#v=o

WHO. (2020a). Cancer Today. GLOBOCAN. https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=population&mode_population=hdi&population=900&populations=900&key=asr&sex=2&cancer=20&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&incl

WHO. (2020b). Who Report on Cancer. World Health Organization. https://apps.who.int/iris/handle/10665/330745

Published

27/07/2022

How to Cite

VILAS-LOBO, G. R.; SANTOS, R. da S.; SILVA, R. R. da. Screening mammography in SUS before and during the Covid-19 Pandemic: a comparison between biennia . Research, Society and Development, [S. l.], v. 11, n. 10, p. e210111032738, 2022. DOI: 10.33448/rsd-v11i10.32738. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/32738. Acesso em: 3 oct. 2022.

Issue

Section

Health Sciences